AI assistant
Sending…
Armata Pharmaceuticals, Inc. — Director's Dealing 2015
Nov 9, 2015
34152_dirs_2015-11-09_327cc121-3305-4e9d-9e0d-764f4425d3c4.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: AmpliPhi Biosciences Corp (APHB)
CIK: 0000921114
Period of Report: 2015-11-05
Reporting Person: GRINT PAUL C (Director)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-11-05 | Stock Option (Right to Buy) | $5.65 | A | 16200 | Acquired | 2025-11-04 | Common Stock (16200) | Direct |
Footnotes
F1: 25% of the shares subject to the Stock Option shall vest on November 5, 2016, and the remaining shares shall vest in 36 equal monthly installments thereafter.
More from Armata Pharmaceuticals, Inc.
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 7
Annual Report
2026
Apr 27
Board/Management Information
2026
Apr 27
Annual Report
2026
Mar 25
Regulatory Filings
2026
Mar 19
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Regulatory Filings
2026
Feb 23